Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
February 27, 2020
We are monitoring the Coronavirus situation very carefully. The health and safety of our meeting attendees and staff are our number one priority. ENDO 2020 will take place as scheduled but as this is an evolving situation worldwide, we will continue to monitor and provide updates on our FAQ page, as necessary.
January 28, 2020
We know that clinicians and their patients have questions about endocrine-disrupting chemicals (EDCs). Compelling scientific evidence in recent decades has established strong links between chemical exposures and endocrine diseases, and patients may want to know about the evidence relating EDCs to specific diseases, or how they can control their exposures and reduce risks for themselves and their families.
February 17, 2020
A Clinical Practice Guideline update has been released, which recommend romosozumab under selective criteria as another pharmacological therapy to improve osteoporosis and reduce fracture risk in postmenopausal women.
February 21, 2020
Conference Event are developed through Endocrine Society’s Continuing Medical Education Services and Special Programs Committee. These events will be held during ENDO at the San Francisco Marriott Marquis.
February 21, 2020
Senator Grassley answered an insulin pricing question we submitted through STAT news, the CDC released updated diabetes statistics, and the White House issued an RFI on the topic of Public Access.
Need more info?
Learn more about the advantages of membership
February 19, 2020
Eating a big breakfast rather than a large dinner may prevent obesity and high blood sugar, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
February 18, 2020
The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture.
February 10, 2020
The Endocrine Society is pleased a South Dakota bill that would have barred healthcare providers from treating transgender teenagers using evidence-based clinical practice guidelines is not moving forward this session.
